Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PA-DFNet: Polarity-Aware Attention Network with Feature Dynamic Fusion for Point Cloud Classification and Semantic Segmentation.

Sensors (Basel, Switzerland)·2026
Same author

Explainable Machine-learning Model Based on Multimodal Ultrasound for Non-invasive Detection of Early Renal Fibrosis: A Multicenter Study.

Academic radiology·2026
Same author

A large cohort analysis of metabolic signatures underlying the liver-eye axis.

Communications medicine·2026
Same author

Histone Variant H2A.Z2 Hyper-Transcription Induced by E2F1 Accelerates Lung Adenocarcinoma Progression via the JAK-STAT Signaling Pathway.

Thoracic cancer·2026
Same author

Treatment effects prediction and clinical decision-making system for retinal vein occlusion by artificial intelligence.

NPJ digital medicine·2026
Same author

From generalization to precision: A large domain-specific pretrained model for specialized medical tasks.

Cell reports. Medicine·2026

Related Experiment Video

Updated: May 12, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K

Explainable deep learning and virtual evolution identifies antimicrobial peptides with activity against

Beilun Wang1, Peijun Lin2, Yuwei Zhong3

  • 1School of Computer Science and Engineering, Southeast University, Nanjing, China. beilun@seu.edu.cn.

Nature Microbiology
|January 17, 2025
PubMed
Summary

Artificial intelligence (AI) accelerates antimicrobial peptide (AMP) discovery. An AI model, EvoGradient, identified and optimized novel AMPs from human oral bacteria, showing potent activity against multidrug-resistant pathogens.

More Related Videos

Quantification of Plasmid-Mediated Antibiotic Resistance in an Experimental Evolution Approach
12:32

Quantification of Plasmid-Mediated Antibiotic Resistance in an Experimental Evolution Approach

Published on: December 14, 2019

13.9K
A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
09:34

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data

Published on: September 25, 2021

3.9K

Related Experiment Videos

Last Updated: May 12, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K
Quantification of Plasmid-Mediated Antibiotic Resistance in an Experimental Evolution Approach
12:32

Quantification of Plasmid-Mediated Antibiotic Resistance in an Experimental Evolution Approach

Published on: December 14, 2019

13.9K
A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
09:34

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data

Published on: September 25, 2021

3.9K

Area of Science:

  • Biotechnology
  • Computational Biology
  • Infectious Diseases

Background:

  • Antimicrobial resistance (AMR) is a growing global health threat.
  • Novel antimicrobial compounds are urgently needed to combat resistant pathogens.
  • Artificial intelligence (AI) offers a powerful approach for drug discovery.

Purpose of the Study:

  • To develop an AI-driven platform for identifying and optimizing antimicrobial peptides (AMPs).
  • To apply this platform to discover novel AMPs from under-explored microbial sources.
  • To validate the efficacy of computationally designed AMPs against multidrug-resistant (MDR) bacteria.

Main Methods:

  • Developed EvoGradient, an explainable deep learning model for predicting AMP potency and guiding sequence modification.
  • Applied EvoGradient to virtually evolve peptides from low-abundance human oral bacteria.
  • Synthesized and experimentally validated top computationally designed AMP candidates against a panel of MDR pathogens.
  • Conducted in vivo studies using mouse models to assess the therapeutic potential of the most potent AMP.

Main Results:

  • EvoGradient successfully identified 32 potent AMP candidates through in silico directed evolution.
  • Six synthesized AMPs demonstrated significant activity against carbapenem-resistant Enterobacteriaceae (e.g., E. coli, K. pneumoniae), Acinetobacter baumannii, and vancomycin-resistant Enterococcus faecium.
  • The lead compound, pep-19-mod, achieved >95% bacterial load reduction in vivo in mouse thigh infection models via systemic and local administration.

Conclusions:

  • AI-driven in silico directed evolution is an effective strategy for discovering and optimizing novel AMPs.
  • The developed EvoGradient platform can accelerate the identification of promising antimicrobial drug candidates.
  • This approach holds significant potential for addressing the challenge of antimicrobial resistance.